Biblio
Export 1207 results:
Author Title [ Type
Filters: First Letter Of Last Name is R [Clear All Filters]
“Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 3, pp. 903-910, 2020.
, “Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 3, pp. 903-910, 2020.
, “Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 3, pp. 903-910, 2020.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.
, “Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.”, J Alzheimers Dis, vol. 58, no. 1, pp. 123-137, 2017.
, “Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review.”, J Alzheimers Dis, vol. 79, no. 1, pp. 95-116, 2021.
, “Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review.”, J Alzheimers Dis, vol. 79, no. 1, pp. 95-116, 2021.
, “Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.”, J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
, “Elevated Pure Tone Thresholds Are Associated with Altered Microstructure in Cortical Areas Related to Auditory Processing and Attentional Allocation.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1163-1172, 2023.
, “Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 1, pp. 117-136, 2018.
, “Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “An epigenetic blockade of cognitive functions in the neurodegenerating brain.”, Nature, vol. 483, no. 7388, pp. 222-6, 2012.
, “Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.”, J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
, “Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.”, J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
, “Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
, “Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
, “Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1235-1244, 2018.
, “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
, “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
, “Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1309-1322, 2018.
,